Capricor Therapeutics CAPR Business Segments — Income Tax Expense Benefit

Similar metrics at other companies

VERXSingle Reportable — Income Tax Expense Benefit

$7.14M+39.8%

ACLSSingle Reportable — Income Tax Expense Benefit

$1.41M-68.7%

DGSingle Reportable — Income Tax Expense Benefit

$147.15M+23.1%

ONTOSingle Reportable — Income Tax Expense Benefit

$6.54M+39.2%

NSSCSingle Reportable — Income Tax Expense Benefit

$206K-89.1%

PAYOSingle Reportable — Income Tax Expense Benefit

$9.64M+34.1%

Questions, answered.

What is Capricor Therapeutics's business segments — income tax expense benefit?

Capricor Therapeutics (CAPR) reported business segments — income tax expense benefit of $400 in Q4 2025.

How has Capricor Therapeutics's business segments — income tax expense benefit changed year-over-year?

Capricor Therapeutics's business segments — income tax expense benefit decreased by 0.0% year-over-year, from $400 to $400.

What does business segments — income tax expense benefit mean?

This represents the amount of income tax expense accrued or the benefit recognized by the company based on its taxable earnings or losses. For companies with significant operating losses, this often reflects minimal tax liability or potential deferred tax assets. It is a necessary component for calculating the final net income of the business.